Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
复制标题
DOI:
10.1007/s00125-018-4720-1
复制
发表时间:
2018-12
期刊:
影响因子:
8.2
通讯作者:
Scherer PE
中科院分区:
文献类型:
--
作者:
Neeland IJ;Singh S;McGuire DK;Vega GL;Roddy T;Reilly DF;Castro-Perez J;Kozlitina J;Scherer PE
Ceramides are sphingolipids that contribute to insulin resistance in preclinical studies. We hypothesised that plasma ceramides would be associated with body fat distribution, insulin resistance and incident type 2 diabetes in a multi-ethnic cohort. A total of 1557 participants in the Dallas Heart Study without type 2 diabetes underwent measurements of metabolic biomarkers, fat depots by MRI, and plasma ceramides by liquid chromatography-mass spectrometry. Diabetes outcomes were assessed after 7 years. Associations of body fat and insulin resistance with ceramides at baseline and of ceramides with incident diabetes outcomes were analysed. The cohort had mean age 43 years, with 58% women, 45% African-Americans and mean BMI 28 kg/m2. Total cholesterol levels were associated with all ceramides, but higher triacylglycerols and lower HDL-cholesterol and adiponectin were associated only with saturated fatty acid chain ceramides (p<0.0003). After adjusting for clinical characteristics and total body fat, visceral adipose tissue was positively associated with saturated fatty acid ceramides (per SD, β= 0.16 to 0.18) and inversely associated with polyunsaturated fatty acid ceramides (β= −0.14 to −0.16, p<0.001 for all). Lower-body subcutaneous fat showed an opposite pattern to that for visceral fat. HOMA-IR was positively associated with saturated (β=0.08 to 0.09, p<0.001) and inversely with polyunsaturated ceramides (β=−0.06 to −0.07, p<0.05). Ceramides were not associated with incident type 2 diabetes after adjustment for clinical factors. Plasma ceramides demonstrate a biologically complex relationship with metabolic and imaging indicators of dysfunctional adiposity. The role of ceramides in a shared pathway of metabolic dysfunction linking visceral adiposity and insulin resistance requires further investigation.
登录
查看更多内容
影响因子:
5.8
作者:
de la Maza, M. P.;Rodriguez, J. M.;Bunout, D.
通讯作者:
Bunout, D.
影响因子:
1.9
作者:
Blachnio-Zabielska, Agnieszka U.;Baranowski, Marcin;Hirnle, Tomasz;Zabielski, Piotr;Lewczuk, Anna;Dmitruk, Iwona;Gorski, Jan
通讯作者:
Gorski, Jan
DOI:
10.1016/j.metabol.2016.11.008
发表时间:
2017-02
期刊:
Metabolism: clinical and experimental
影响因子:
--
作者:
Neeland IJ;Hughes C;Ayers CR;Malloy CR;Jin ES
通讯作者:
Jin ES
影响因子:
13.8
作者:
Petersen MC;Shulman GI
通讯作者:
Shulman GI
影响因子:
24
作者:
Chandra, Alvin;Neeland, Ian J.;Turer, Aslan T.
通讯作者:
Turer, Aslan T.